Elobixibat
- Generic Name
- Elobixibat
- Drug Type
- Small Molecule
- Chemical Formula
- C36H45N3O7S2
- CAS Number
- 439087-18-0
- Unique Ingredient Identifier
- 865UEK4EJC
- Background
Elobixibat has been used in trials studying the treatment and basic science of Dyslipidemia, Constipation, Chronic Constipation, Functional Constipation, and Chronic Idiopathic Constipation.
Study of A3309 in Patients With Dyslipidemia
- First Posted Date
- 2010-02-17
- Last Posted Date
- 2024-03-07
- Lead Sponsor
- Albireo
- Target Recruit Count
- 36
- Registration Number
- NCT01069783
- Locations
- 🇸🇪
BCRC, Linköping, Sweden
Effect of Ileal Bile Acid Transporter Inhibitor in Functional Constipation
- First Posted Date
- 2009-12-24
- Last Posted Date
- 2020-09-04
- Lead Sponsor
- Michael Camilleri, MD
- Target Recruit Count
- 36
- Registration Number
- NCT01038687
- Locations
- 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
Study of Elobixibat (A3309) in Patients With Chronic Idiopathic Constipation
- First Posted Date
- 2009-11-03
- Last Posted Date
- 2017-03-22
- Lead Sponsor
- Albireo
- Target Recruit Count
- 190
- Registration Number
- NCT01007123
- Locations
- 🇺🇸
Albireo Investigative Site, La Crosse, Wisconsin, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath